Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ADAMTS13, RECOMBINANT-KRHN for Prophylaxis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 7 adverse event reports in the FDA FAERS database where ADAMTS13, RECOMBINANT-KRHN was used for Prophylaxis.

Most Reported Side Effects for ADAMTS13, RECOMBINANT-KRHN

Side Effect Reports % Deaths Hosp.
Pregnancy 9 13.2% 0 2
No adverse event 7 10.3% 0 0
Thrombotic thrombocytopenic purpura 6 8.8% 0 1
Abortion spontaneous 5 7.4% 0 0
Headache 5 7.4% 0 0
Incorrect dose administered 5 7.4% 0 1

Other Indications for ADAMTS13, RECOMBINANT-KRHN

Thrombotic thrombocytopenic purpura (32) Product used for unknown indication (17) Congenital thrombotic thrombocytopenic purpura (13)

Other Drugs Used for Prophylaxis

PEGFILGRASTIM (7,424) HUMAN C1-ESTERASE INHIBITOR (5,950) DENOSUMAB (4,541) SULFAMETHOXAZOLE\TRIMETHOPRIM (3,197) ASPIRIN (2,083) VALACYCLOVIR (1,574) PANTOPRAZOLE (1,502) VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN (1,444) CLOPIDOGREL BISULFATE (1,296) ENOXAPARIN (1,278)

Related Pages

ADAMTS13, RECOMBINANT-KRHN Full Profile All Prophylaxis Drugs ADAMTS13, RECOMBINANT-KRHN Demographics ADAMTS13, RECOMBINANT-KRHN Timeline